Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by GunnerGon Jun 04, 2021 8:41pm
171 Views
Post# 33335107

Two weeks ago - May 21st

Two weeks ago - May 21stwe optioned our only revenue product (Ryplazim) and 70% of the NET PROCEEDS of voucher for $5M.

So we gave up a revenue stream of who knows how much money and $30M of the $100M voucher to Kedrion for a whooping $5M and this pumping clown thinks this is great for us.  Two weeks to FDA decision and management does this. 

We had nothing to lose by waiting.  Instead, we gave away the farm.

Now we maybe have $92M cash and no revenue stream.  TV will get most of that money through interest payments on the loans.

Had we waiting two weeks, we had a revenue stream plus a voucher of $100M.
<< Previous
Bullboard Posts
Next >>